{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T05:37:49Z","timestamp":1761197869379,"version":"build-2065373602"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Michael J Fox Foundation"},{"name":"Italian Ministry of Health","award":["RC1812C"],"award-info":[{"award-number":["RC1812C"]}]},{"name":"Chiesi Farmaceutici SpA"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.parkreldis.2020.11.008","type":"journal-article","created":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T07:46:55Z","timestamp":1605340015000},"page":"7-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Levodopa-responsive progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor antibodies"],"prefix":"10.1016","volume":"82","author":[{"given":"Andrea","family":"Sturchio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Gastaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia Princiotta","family":"Cariddi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Biacchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto J.","family":"Espay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Franciotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Versino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Mauri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2020.11.008_bib1","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/brain\/awu142","article-title":"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes","volume":"137","author":"Carvajal-Gonz\u00e1lez","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2020.11.008_bib2","doi-asserted-by":"crossref","first-page":"e592","DOI":"10.1212\/NXI.0000000000000592","article-title":"Novel clinical features of glycine receptor antibody syndrome: a series of 17 cases","volume":"6","author":"Piquet","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.parkreldis.2020.11.008_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ymgme.2009.02.001","article-title":"Tyrosine hydroxylase deficiency with severe clinical course","volume":"97","author":"Zafeiriou","year":"2009","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.parkreldis.2020.11.008_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ymgme.2006.03.010","article-title":"Sepiapterin reductase deficiency an autosomal recessive DOPA-responsive dystonia","volume":"89","author":"Abeling","year":"2006","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.parkreldis.2020.11.008_bib5","series-title":"Oculogyric crises: a review of phenomenology, etiology, pathogenesis, and treatment","first-page":"193","author":"Slow","year":"2017"},{"key":"10.1016\/j.parkreldis.2020.11.008_bib6","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/cne.21349","article-title":"Glycine receptors in the striatum, globus pallidus, and substantia nigra of the human brain: an immunohistochemical study","volume":"502","author":"Waldvogel","year":"2007","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.parkreldis.2020.11.008_bib7","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1093\/brain\/awz297","article-title":"Glycine receptor autoantibodies disrupt inhibitory neurotransmission","volume":"142","author":"Crisp","year":"2019","journal-title":"Brain"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802020308592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802020308592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:20:00Z","timestamp":1761178800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802020308592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":7,"alternative-id":["S1353802020308592"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.11.008","relation":{},"ISSN":["1353-8020"],"issn-type":[{"type":"print","value":"1353-8020"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levodopa-responsive progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor antibodies","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}